Publications and Presentations Database

Sort by: Author Title [ Type (Desc)] Year
Journal Article
Hock, K. T., Christensen, K. D., Yashar, B. M., Roberts, J. S., Gollust, S. E., & Uhlmann, W. R. (2011).  Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs. Genetics in medicine : official journal of the American College of Medical Genetics. 13(4), 325-32. Abstract
Gornick, M. C., Ryan, K. A., Scherer, A. M., Roberts, J. S., De Vries, R. G., & Uhlmann, W. R. (Submitted).  Interpretations of the term "actionable" when discussing genetic test results: What you mean is not what I heard. Journal of Genetic Counseling. Abstract
Invited Presentation
Uhlmann, W. R. (2005).  Genetic Counseling and Ethical Issues.
Roberts, J. S., & Uhlmann, W. R. (2012).  “The REVEAL (Risk Evaluation and Education for Alzheimer’s Disease) Study,” .
Uhlmann, W. R. (2012).  “The Swinging Gate: Genetic Testing and Ethical Issues,” .
Conference Presentation
Uhlmann, W. R. (2014).  Bioethics Grand Rounds: "Genetic Testing of Children for Adult-Onset Conditions: Ethical Considerations".
Uhlmann, W. R. (2013).  Bioethics Grand Rounds: "The Swinging Gate: Genetic Testing and Ethical Issues".
Roberts, J. S., Uhlmann, W. R., Petersen, R., Karlawish, J., & Green, R. C. (2009).  Clinical practices regarding Mild Cognitive Impairment (MCI) among neurology service providers.
Szymaniak, J. M., Christensen, K. D., Uhlmann, W. R., Green, R. C., & Roberts, J. S. (2009).  A Condensed Genetic Counseling Approach for Alzheimer's Diseases Susceptibility Testing: What is the Psychological Impact? .
Le, L. Q., Bartnik, N. J., Christensen, K. D., Uhlmann, W. R., Karlawish, J., Obisesan, T., et al. (2016).  Educating Patients and Care Partners about Mild Cognitive Impairment, APOE, and Alzheimer’s Disease: Findings from the REVEAL Study.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al. (2010).  How does pleiotropic information affect health behavior changes? Initial results from the REVEAL Study, a randomized trial of genetic testing for Alzheimer’s disease.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al. (2009).  The Impact of Pleiotropic Information about Cardiovascular Disease Risk on Health Behavior Changes among People Seeking Genetic Susceptibility Testing for Alzheimer’s Disease: Initial Results from a Randomized Trial.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Royal, C. D. M., Obisesan, T., et al. (2010).  Perceived personal utility of Alzheimer’s disease genetic susceptibility testing and its influence on post-test responses: Findings from the REVEAL Study.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al. (2010).  The psychological impact of learning APOE ε4 increases the risk for cardiovascular disease during genetic risk assessment for Alzheimer’s disease: Findings from the REVEAL Study.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Cupples, L. A., et al. (2010).  Telephone and in-person disclosure of genetic test results: 6-week recall, comprehension, and distress among participants in the REVEAL Study.